These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23929701)

  • 1. Multicenter trial of the proficiency of smart quantitative sensation tests.
    Dyck PJ; Argyros B; Russell JW; Gahnstrom LE; Nalepa S; Albers JW; Lodermeier KA; Zafft AJ; Dyck PJ; Klein CJ; Litchy WJ; Davies JL; Carter RE; Melton LJ;
    Muscle Nerve; 2014 May; 49(5):645-53. PubMed ID: 23929701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
    J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
    Dimitrakoudis D; Bril V
    Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.
    Dyck PJ; Dyck PJ; Larson TS; O'Brien PC; Velosa JA
    Diabetes Care; 2000 Apr; 23(4):510-7. PubMed ID: 10857944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
    Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
    Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of blink reflex R1 latency as an electrophysiological marker in diabetic distal symmetrical polyneuropathy.
    Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
    Clin Neurophysiol; 2020 Jan; 131(1):34-39. PubMed ID: 31751837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy.
    Nasseri K; Strijers RL; Dekhuijzen LS; Buster M; Bertelsmann FW
    Electromyogr Clin Neurophysiol; 1998; 38(5):295-9. PubMed ID: 9741007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibration perception threshold in the screening of sensorimotor distal symmetric polyneuropathy: the need of more accurate age-specific reference values.
    Maffei L; Premrou V; Roldan P; Copetti M; Pellegrini F; Rossi MC; Vespasiani G
    J Diabetes Sci Technol; 2014 May; 8(3):621-2. PubMed ID: 24876629
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining loss of protective sensation in the diabetic foot.
    Wunderlich RP; Armstrong DG; Husain K; Lavery LA
    Adv Wound Care; 1998; 11(3):123-8. PubMed ID: 9729943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer assisted sensory examination to detect and quantitate sensory deficit in diabetic neuropathy.
    Dyck PJ; Karnes J; Bushek W; Spring E; O'Brien PC
    Neurobehav Toxicol Teratol; 1983; 5(6):697-704. PubMed ID: 6669185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments.
    Zinman LH; Bril V; Perkins BA
    Diabetes Care; 2004 Jul; 27(7):1674-9. PubMed ID: 15220245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing.
    Sorensen L; Molyneaux L; Yue DK
    Clin J Pain; 2006; 22(3):261-5. PubMed ID: 16514326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.
    Raputova J; Srotova I; Vlckova E; Sommer C; Üçeyler N; Birklein F; Rittner HL; Rebhorn C; Adamova B; Kovalova I; Kralickova Nekvapilova E; Forer L; Belobradkova J; Olsovsky J; Weber P; Dusek L; Jarkovsky J; Bednarik J
    Pain; 2017 Dec; 158(12):2340-2353. PubMed ID: 28858986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathy.
    Pinto MV; Dyck PJB; Gove LE; McCauley BM; Ackermann EJ; Hughes SG; Waddington-Cruz M; Dyck PJ
    J Neurol Sci; 2018 Nov; 394():78-83. PubMed ID: 30219500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
    Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
    Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial.
    Dyck PJ; Overland CJ; Low PA; Litchy WJ; Davies JL; Dyck PJ; O'Brien PC; ; Albers JW; Andersen H; Bolton CF; England JD; Klein CJ; Llewelyn JG; Mauermann ML; Russell JW; Singer W; Smith AG; Tesfaye S; Vella A
    Muscle Nerve; 2010 Aug; 42(2):157-64. PubMed ID: 20658599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative sensory testing in patients with polyneuropathy and healthy individuals.
    Nebuchennykh M; Løseth S; Stålberg E; Mellgren SI
    Acta Neurol Scand Suppl; 2008; 188():56-61. PubMed ID: 18439223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.